📰 Mark Swallow News
Page 8 - Mark Swallow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Swallow. Real-time updates on events, politics, business and more.
January 6, 2022
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...
December 16, 2021
Investegate announcements from Acacia Pharma Group plc, Correction: Issue of Shares to Employee Benefit Trust
November 29, 2021
- Series B co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC, alongside founding investor Syncona and includes a broad
November 29, 2021
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...
November 22, 2021
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...
November 4, 2021
- First clinical proof of concept data with lead OncoMimics therapeutic cancer vaccine candidate EO2401 expected in H1 2022 - New Corporate Identity and Website Launched Today PARIS
November 4, 2021
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its unique ability to decode the...
October 27, 2021
/PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy,...
October 27, 2021
Former Chair and CEO of Swedish Orphan Biovitrum brings a wealth of industry and leadership experience to Cytovation BERGEN, Norway, Oct. 27, 2021 /PRNewswire/ -- Cytovation AS, a clinical
October 27, 2021
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...